2012•Western Journal of Traditional Chinese MedicineRequires access

Clinical Observation on Modified XuanBiTang and ErMiaoSan in Treating Rheumatoid Arthritis

Zhang Zhen-shun

Open publisher page 1 citations

Abstract

Objective: To explore clinical of modified XuanBiTang and ErMiaoSan in treating rheumatoid arthritis(RA).Method: Seventy patients were randomly divided into treatment group and control group.Treatment group received modified XuanBiTang and ErMiaoSan based on syndrome differentiation and treatment,control group were administered with routine western medicine.Incidence of adverse reaction and clinical effects before and after treating were observed after treating for eight weeks.Result: Total effective rate of treatment group was 94.29%,higher than 74.29% of control group with statistical meaning(P0.05);comparison between both groups suggested difference in incidence of adverse events and it indicated no statistical meaning(P0.05).Conclusion: Modified XuanBiTang and ErMiaoSan are effective in treating rheumatoid arthritis significantly freeing from side effects.

About this research paper

What this paper is about

Objective: To explore clinical of modified XuanBiTang and ErMiaoSan in treating rheumatoid arthritis(RA).Method: Seventy patients were randomly divided into treatment group and control group.Treatment group received modified XuanBiTang and ErMiaoSan based on syndrome differentiation and treatment,control group were administered with routine western medicine.Incidence of adverse reaction and clinical effects before and after treating were observed after treating for eight weeks.Result: Total effective rate of treatment group was 94.29%,higher than 74.29% of control group with statistical meaning(P0.05);comparison between both groups suggested difference in incidence of adverse events and it indicated no statistical meaning(P0.05).Conclusion: Modified XuanBiTang and ErMiaoSan are effective in treating rheumatoid arthritis significantly freeing from side effects.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore clinical of modified XuanBiTang and ErMiaoSan in treating rheumatoid arthritis(RA).Method: Seventy patients were randomly divided into treatment group and control group.Treatment group received modified XuanBiTang and ErMiaoSan based on syndrome differentiation and treatment,control group were administered with routine western medicine.Incidence of adverse reaction and clinical effects before and after treating were observed after treating for eight weeks.Result: Total effective rate of treatment group was 94.29%,higher than 74.29% of control group with statistical meaning(P0.05);comparison between both groups suggested difference in incidence of adverse events and it indicated no statistical meaning(P0.05).Conclusion: Modified XuanBiTang and ErMiaoSan are effective in treating rheumatoid arthritis significantly freeing from side effects.

Key concepts: Medicine, Rheumatoid arthritis, Incidence (geometry), Adverse effect, Internal medicine, Western medicine, Treatment and control groups, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation on Modified XuanBiTang and ErMiaoSan in Treating Rheumatoid Arthritis — Research Paper | ScholarLens